الاتحاد الأوروبي - التشيكية - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - azacitidin - leukemie, myeloidní, akutní - antineoplastická činidla - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).

الاتحاد الأوروبي - التشيكية - EMA (European Medicines Agency)

mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotické činidla - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

الاتحاد الأوروبي - التشيكية - EMA (European Medicines Agency)

pfizer europe ma eeig  - abrocitinib - dermatitida, atopická - ostatní dermatologické přípravky - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.

الاتحاد الأوروبي - التشيكية - EMA (European Medicines Agency)

amgen europe bv - sotorasib - karcinom, plicní jiná než malobuněčná - antineoplastická činidla - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.

الاتحاد الأوروبي - التشيكية - EMA (European Medicines Agency)

eigerbio europe limited - lonafarnib - progeria; laminopathies - jiné zažívací trakt a produkty metabolismu, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.

جمهورية التشيك - التشيكية - SUKL (Státní ústav pro kontrolu léčiv)

dr. falk pharma gmbh, freiburg array - 5362 budesonid - enterosolventní tvrdá tobolka - 3mg - budesonid

جمهورية التشيك - التشيكية - SUKL (Státní ústav pro kontrolu léčiv)

dr. falk pharma gmbh, freiburg array - 5362 budesonid - enterosolventní granule - 9mg - budesonid

جمهورية التشيك - التشيكية - SUKL (Státní ústav pro kontrolu léčiv)

stada arzneimittel ag, bad vilbel array - 9476 cilostazol - tableta - 100mg - cilostazol

جمهورية التشيك - التشيكية - SUKL (Státní ústav pro kontrolu léčiv)

adamed pharma s.a., czosnów polsko - 9476 cilostazol - tableta - 100mg - cilostazol

جمهورية التشيك - التشيكية - SUKL (Státní ústav pro kontrolu léčiv)

adamed pharma s.a., czosnów polsko - 9476 cilostazol - tableta - 50mg - cilostazol